Interleukin 7 (IL-7) is a 25-kDa cytokine which was purified and its corresponding cDNA was cloned based upon its ability to stimulate the proliferation of pre-B cells. It has been shown that IL-7 can also function as a costimulator with Con A for the proliferation of T lymphocytes by inducing the production of interleukin 2 (IL-2). We demonstrate here that IL-7 in combination with phorbol 12-myristate 13-acetate can directly drive the proliferation of purified T cells and that this response is not inhibited by cyclosporine A or by antibodies to IL-2 and IL-4. Stimulation of T cells with phorbol myristate acetate and IL-2, IL-4, or IL-7 prepared T cells to respond to any of the three lymphokines.
IL-7 may play a role in T-cell growth and differentiation in vivo.
Although many of the interleukins were initially characterized as having functional effects on a single cell type, multiple studies over the past 5 years have demonstrated that almost all of the interleukins exhibit pleiotropic effects on a wide variety of both lymphoid and nonlymphoid cells. Interleukin 2 (IL-2) was originally considered to be the sole T-cell growth factor (1) . However, IL-4, which was originally characterized as a B-cell growth factor (2), has been found to induce T-cell proliferation in an IL-2-independent manner (3), and IL-6, which was initially recognized as a B-cell differentiation and hybridoma growth factor (4), subsequently was also found to function as a T-cell growth factor in either an IL-2-dependent (5) or an IL-2-independent (6) manner.
IL-7 is a 25-kDa glycoprotein that was purified (7) and the corresponding cDNA was cloned (8, 9) based upon its ability to stimulate the proliferation of pre-B cells. Morrissey et al. (10) have recently shown that IL-7 can function as a costimulator for the proliferation of T cells depleted of accessory cells (AC) by inducing the production of IL-2. In the present study, we demonstrate that IL-7 and phorbol 12-myristate 13-acetate (PMA) induce resting T cells to synthesize DNA by an IL-2-independent pathway and also induce responsiveness to IL-7, IL-2, and IL-4.
MATERIALS AND METHODS Animals. C57BL/6J and BALB/c female mice, 8 Culture Medium and Conditions. Cultures, unless otherwise indicated, were performed in R10, which consists of RPMI 1640 medium (Biofluids, Rockville, MD) supplemented with L-glutamine (300 Ag/ml), penicillin (100 units/ ml), streptomycin (100 /g/ml), 2-mercaptoethanol (50 ,uM), and 10% heat-inactivated fetal calf serum (FCS).
Reagents and Monoclonal Antibodies (mAbs). Con A and PMA were purchased from Pharmacia and Sigma, respectively. Cyclosporine A (CsA)-(Sandimmune I.V.) was a gift of Sandoz Pharmaceuticals. Low-Tox-M activated rabbit complement (C) was purchased from Cedarlane Laboratories. Recombinant human (rh) IL-2 was kindly provided by Cetus, recombinant murine (rm) IL-4 was the gift of W. Paul (National Institutes of Health), and rmIL-7 [from COS-7 cells transfected with expression plasmid pDC201 containing the IL-7 cDNA insert 1046B (8)] was generously supplied by Immunex. Supernatant from splenocytes cultured with Con A and then supplemented with methyl a-D-mannopyranoside (20 mg/ml, Sigma) was used as a source of murine IL-2. mAbs HO-13-4 (anti-Thy 1.2) (11), M5/114.15.2 (anti-Ia) (12), MAR 18.5 (anti-rat K) (13), GK1.5 (anti-L3T4) (14) , 53.6.7 (anti-Lyt-2) (15), S4B6.1 (anti-murine IL-2) (16), and liB11 (anti-murine IL-4) (17) were used as dilute ascites fluid. mAb S4B6.1 ascites fluid was used at a final concentration of 1:40, at which it was able to specifically neutralize 50-100 units (U)/ml of murine IL-2 in a CTLL assay (3) . mAb ilB11 ascites fluid was used at a final concentration of 1:400, at which it was able to specifically neutralize 2500-5000 U/ml of rmIL-4 in a bioassay. One unit of lymphokine is defined as that quantity which results in half-maximal [3H]thymidine uptake by an indicator cell line in a bioassay. At the concentrations used, neither mAb S4B6.1 nor mAb liB11 crossreacted, respectively, with IL-4 or IL-2. Monoclonal antibody 145-2C11 (anti-CD3 e) (18) was purified from culture supernatant by affinity chromatography on a staphylococcal protein A-Sepharose 4B column.
Preparation of Resting T Cells and AC. Highly purified T cells were prepared by passage of mesenteric lymph node cells twice over nylon wool columns followed by serial treatments with M5/114 + C and MAR 18.5 + C. T-cell subsets were prepared by the addition of either GK1.5 or 53.6.7 to the incubation mixture with M5/114. The purity of these populations was confirmed by fluorescent flow cytometric analysis. Non-T AC were prepared as previously described (19) and irradiated with 3000 rads (1 rad = 0.01 Gy). (2) . To evaluate whether IL-7 would also function as a costimulator of T-cell proliferation, highly purified T lymphocytes were cultured in the presence of IL-7, PMA, or the combination of IL-7 and PMA. Neither IL-7 nor PMA was mitogenic for resting T cells, but a marked proliferative response was observed when T cells were cultured in the presence of both agents (Fig. 1) . In general, in multiple experiments of this type, the proliferative response to IL-7 and PMA was similar in magnitude to that seen with the combination of IL-4 and PMA but was consistently less than the response to IL-2 and PMA. Importantly, supernatants from mock-transfected COS-7 cells not containing the IL-7 cDNA failed, both in the presence and in the absence of PMA, to induce T-cell DNA synthesis (data not shown). It is unlikely that the proliferative response to IL-7 and PMA was mediated by a small subpopulation of the resting T cells or by contaminating B cells because 30%o of the responding population exhibited a 2-to 4-fold increase in cell volume 36 hr after stimulation (data not shown). Furthermore, proliferative responses of a magnitude similar to that seen in the unfractionated population could be induced in highly purified CD4' and CD8' T-cell subsets (Table 1) . The Proliferative Response to IL-7/PMA Is IL-2 Independent. Although IL-7 appeared to function as a costimulant of resting T-cell proliferation, the possibility remained open that the effects of IL-7 were indirect and mediated by induction of the production of either IL-2 or IL-4, which would themselves trigger T-cell proliferation in the presence of PMA. However, supernatants of T cells stimulated with IL-7 and PMA did not contain quantities of IL-2 or IL-4 detectable in bioassays (data not shown). To definitively rule out the possibility of IL-2 or IL-4 production in the response to IL-7, highly purified T cells were stimulated with IL-7 and PMA in the presence of a neutralizing antibody to murine IL-2 (S4B6), a neutralizing antibody to murine IL-4 (liB11), or CsA, an immunosuppressive drug which has been shown to inhibit the transcription of IL-2 (21) and IL-4 (22) mRNAs.
Neither S4B6 nor ilB11 had a significant effect on the proliferative response induced by IL-7 and PMA ( Table 2 ). The addition of CsA produced a 30-50% decrease in the response to IL-7 and PMA but completely abrogated the proliferative response of Con A-stimulated T cells. It is unlikely that the concentrations of anti-lymphokine mAbs used were suboptimal, as the concentration of S4B6 used was capable of inhibiting the proliferative response of resting T cells to a supernatant which contained mouse IL-2 and PMA, while the concentration of ilB11 was similarly capable of inhibiting the proliferative response of the same cell population to stimulation by rmIL-4 and PMA.
Induction 85,662 Highly purified CD4+ and CD8+ T lymphocytes were incubated with PMA (10 ng/ml) and the indicated lymphokine as in Fig. 1 . Incubation of each T-cell subset with medium, PMA, or lymphokine alone yielded less than 1000 cpm.
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Immunology: Chazen et al. (Fig. 3) .
Very different results were observed with draining popliteal lymph node cells activated in vivo by injection of anti-CD3 or allogeneic cells in the footpads. All three lymphokines were capable of inducing a significant proliferative response of the unfractionated lymph node population, purified T cells (2C11-stimulated), or purified CD4 and CD8 subsets (allogeneic cell-stimulated) activated in vivo (Table  3) . Furthermore, the effect of IL-7 on the in vivo activated cells appeared to be direct, as the addition of CsA, antilymphokine antibodies, or a combination of CsA and antilymphokine mAbs produced only a modest reduction in the magnitude of the proliferative responses to any of the lymphokines (Table 3) .
IL-7 Functions as a Costimulator for Con A by an IL-2-Dependent Pathway. Morrissey et al. (10) have recently demonstrated that IL-7 has costimulatory activity for the Con A response of AC-depleted T-cell populations and that this costimulatory function is mediated by inducing the production of IL-2. Because our results on the stimulation of T-cell proliferation by IL-7 and PMA indicated that the proliferative response was independent of IL-2, we repeated the studies of Morrissey et al. and evaluated the costimulatory properties of IL-7 for the Con A response of highly purified T cells. In contrast to the results described by Morrissey et al., we found in three of four experiments that IL-7 had only marginal ability to reconstitute the response of highly purified T cells to Con A (Table 4 , Exp. 1); however, in some studies (Table 4 , Exp. 2) a modest reconstitution of the Con A response was produced by the addition of IL-7. The response to the combination of IL-7 and Con A appeared to be mediated by an IL-2-dependent pathway, as the response was substantially inhibited by the addition of CsA or the addition of the anti-IL-2 mAb but not the addition of anti-IL-4. One possible explanation for the differences between our results and those of Morrissey et al. (10) is that an effect of IL-7 on the Con A response may require the presence of a small number of contaminating AC in the culture. Thus, the T-cell population in Table 4 [3H]Thymidine was added for the last 18 hr of the secondary culture.
The secondary responses of T cells-precultured in medium, PMA, or lymphokine alone were uniformly less than 1500 cpm. Note that the response to IL-2 at the bottom goes off scale; the actual cpm is shown at the right of the bar. Immunology: Chazen et A well) were cultured with medium alone, rmIL-7 (1000 U/ml), rhIL-2 (10 U/ml), or rmIL-4 (800 U/ml) in the presence or absence of CsA (0.25 ug/ml) or CsA + mAbs for 42 hr. ND, not determined.
5-10% contamination by non-T cells (data not shown).
In contrast, the T-cell population used in Table 4 , Exp. 1, demonstrated less than 1% contamination by non-T cells and failed to respond to Con A alone. DISCUSSION IL-7 was originally identified as a stromal cell-derived soluble factor that was capable of supporting the growth of pre-B cells in vitro in the absence of any stromal cells. The availability of a specific bioassay for IL-7 activity facilitated its purification and subsequent cloning. Although the biologic activity of IL-7 was originally considered to be specific for pre-B cells, Morrissey et al. (10) have recently shown that IL-7 can provide a costimulatory signal for the in vitro proliferative response of purified murine T cells to Con A by inducing IL-2 production.
In the present report, we have extended these findings and demonstrated that IL-7 in combination with PMA can directly drive T-cell activation. The proliferative response to the combination of IL-7 and PMA was not inhibited by high concentrations of neutralizing antibodies to IL-2 or IL-4 and was largely resistant to the immunosuppressive effects of CsA, a drug which inhibits the transcription of a number of lymphokine genes, including those encoding IL-2, IL-4, and interferon-y (22) . These results strongly suggest that T-cell activation in this system is not mediated by an autocrine IL-2-dependent pathway. However, it is difficult to exclude the-possibility that IL-7 may induce the production of a Highly purified T cells were cultured with IL-7 (1000 U/ml) and Con A (5 ,g/ml) as in Fig. 1 . When added, AC were 105 per well and CsA was 0.25 ,ug/ml. ND, not determined.
CsA-resistant lymphokine, and the partial susceptibility of the response to CsA may indicate that CsA induces the production of a CsA-sensitive T-cell growth factor other than IL-2 or IL-4.
The induction of responsiveness to IL-7 exhibited a number of characteristics that are both similar and distinct from the induction of responsiveness to either IL-2 or IL-4. Stimulation of T cells with PMA and IL-2, IL-4, or IL-7 prepared T cells to respond to any of the three lymphokines. The secondary response to IL-2 was greater than the secondary response to either IL-7 or IL-4. Surprisingly, T (10) in that in certain experiments IL-7 was able to partially reconstitute the response of AC-depleted T cells to Con A and the reconstitution was mediated by the induction of an IL-2 pathway. However, in contrast to the uniform ability of the same T-cell population to respond to the combination of PMA and IL-7, significant reconstitution of the Con A response by IL-7 was only rarely seen in our experiments. One possible explanation for the difference between our findings and those of Morrissey et al. (10) is the extent of AC depletion of the responder T-cell population. It is thus possible that the production of another cytokine (IL-1 or IL-6?) by contaminating AC is needed for the costimulatory effects of IL-7 on the Con A response.
Although IL-7 was originally described as a cytokine with the pre-B cell as its specific target cell, as has become apparent with continued study of almost all cytokines, most are capable of acting on a wide variety of both lymphoid and nonlymphoid cells. Our studies clearly demonstrate that IL-7 can function both as a progression factor for T-cell growth and, in concert with PMA, as a competence factor for inducing responsiveness to IL-2 or IL-4. The physiologic role of IL-7 in T-cell activation is at present unknown, and most in vitro studies are consistent with the hypothesis that IL-2 and IL-4 are the major T-cell growth factors. However, the demonstration of the constitutive production of IL-7 mRNA by cells from lymphoid and nonlymphoid organs (8) coupled with our observation that responsiveness to IL-7 is induced in vivo, but not in vitro, by stimulation of T cells via the CD3/T-cell receptor complex raises the possibility that IL-7 may play a role equivalent to that of IL-2 or IL-4 in T-cell growth and development in the intact animal.
